Isolation of head and neck squamous carcinoma cancer stem-like cells in a syngeneic mouse model and analysis of hypoxia effect

Oncology Reports

Volumn 28, Issue 3, 2012, Pages 1057-1062

  Duarte, Sónia ^a   Loubat, Agnès ^c   Momier, David ^c   Topi, Majlinda ^c   Faneca, Henrique ^a   Pedroso De Lima, Maria C ^a,b   Carle, Georges F ^c   Pierrefite Carle, Valérie ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

ALDH1 selection; Cancer stem cells; Head and neck squamous cell carcinoma; Hypoxia

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER STEM CELL; CARCINOGENICITY; CELL COUNT; CELL DIFFERENTIATION; CELL GROWTH; CELL HYPOXIA; CELL ISOLATION; CELL POPULATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; ISOENZYMES; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; RETINAL DEHYDROGENASE; SPHEROIDS, CELLULAR; TRANSPLANTATION, ISOGENEIC; TUMOR BURDEN;

EID: 84865312688     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1904     Document Type: Article

References (23)

1. Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet 371: 1695-1709, 2008.
2. Moore SR, Johnson NW, Pierce AM and Wilson DF: The epidemiology of mouth cancer: a review of global incidence. Oral Dis 6: 65-74, 2000.
3. Forastiere A, Koch W, Trotti A and Sidransky D: Head and neck cancer. N Engl J Med 345: 1890-1900, 2001.
4. Forastiere AA, Trotti A, Pfister DG and Grandis JR: Head and neck cancer: recent advances and new standards of care. J Clin Oncol 24: 2603-2605, 2006.
5. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
6. Tabor MH, Clay MR, Owen JH, et al: Head and neck cancer stem cells: the side population. Laryngoscope 121: 527-533, 2011.
7. Li HZ, Yi TB and Wu ZY: Suspension culture combined with chemotherapeutic agents for sorting of breast cancer stem cells. BMC Cancer 8: 135, 2008.
8. Prince ME, Sivanandan R, Kaczorowski A, et al: Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci USA 104: 973-978, 2007.
9. Lim YC, Oh SY, Cha YY, Kim SH, Jin X and Kim H: Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. Oral Oncol 47: 83-91, 2011.
10. Chen H, Zhou L, Dou T, Wan G, Tang H and Tian J: BMI1's maintenance of the proliferative capacity of laryngeal cancer stem cells. Head Neck 33: 1115-1125, 2011.
11. Chen YC, Chen YW, Hsu HS, et al: Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun 385: 307-313, 2009.
12. Clay MR, Tabor M, Owen JH, et al: Singlemarker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 32: 1195-1201, 2010.
13. Ginestier C, Hur MH, Charafe-Jauffret E, et al: ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1: 555-567, 2007.
14. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM and Morrison SJ: Efficient tumour formation by single human melanoma cells. Nature 456: 593-598, 2008.
15. Auerbach R, Morrissey LW and Sidky YA: Regional differences in the incidence and growth of mouse tumors following intra-dermal or subcutaneous inoculation. Cancer Res 38: 1739-1744, 1978.
16. Chen ZG: The cancer stem cell concept in progression of head and neck cancer. J Oncol 2009: 894064, 2009.
17. Frank NY, Schatton T and Frank MH: The therapeutic promise of the cancer stem cell concept. J Clin Invest 120: 41-50, 2010.
18. Sayed SI, Dwivedi RC, Katna R, et al: Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral Oncol 47: 237-243, 2011.
19. Dontu G, Abdallah WM, Foley JM, et al: In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 17: 1253-1270, 2003.
20. RicciVitiani L, Lombardi DG, Pilozzi E, et al: Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111-115, 2007.
21. Cabarcas SM, Mathews LA and Farrar WL: The cancer stem cell niche - there goes the neighborhood? Int J Cancer 129: 2315-2327, 2011.
22. Das B, Tsuchida R, Malkin D, Koren G, Baruchel S and Yeger H: Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction. Stem Cells 26: 1818-1830, 2008.
23. Yeung TM, Gandhi SC and Bodmer WF: Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108: 4382-4387, 2011.